Dr. Rho is a Professor of Paediatrics, Clinical Neurosciences, Physiology and Pharmacology at the University of Calgary, Section Chief of Paediatric Neurology at the Alberta Children’s Hospital, and the inaugural holder of the Dr. Robert Haslam Chair in Child Neurology. He received an undergraduate degree in molecular biophysics and biochemistry at Yale University, and an M.D. from the University of Cincinnati. Dr. Rho has held faculty appointments at the University of Washington (Seattle), the University of California at Irvine, and the Barrow Neurological Institute in Phoenix, Arizona. Dr. Rho’s main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet. His research activities have been sponsored by research grants from the NIH, CIHR, Brain Canada, and a variety of intramural and extramural public and private sector sources.